NewAmsterdam Pharma Co N.V. Stock: price and management transactions · United States · SEC (Form 4)Follow the NewAmsterdam Pharma Co N.V. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 22 July 2026 (Cession). Among the most active insiders: Kooij Louise Frederika. All data is openly available.
€763,264
12 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 July 2026
All Executives90 Thresholds0 Prospectus0 Other0
Declarations 90 total
▼ Chief Accounting Officer · Executives · 20 Jul 2026
70,200 shares @ US$29.96 25.9% of flow Ordinary Shares SEC:0001193125-26-312387:2
▼ Chief Accounting Officer · Executives · 20 Jul 2026
31,885 shares @ US$31.05 12.2% of flow Ordinary Shares SEC:0001193125-26-312387:3
▼ Chief Accounting Officer · Executives · 20 Jul 2026
2,915 shares @ US$31.71 1.1% of flow Ordinary Shares SEC:0001193125-26-312387:4
◇ Chief Accounting Officer · Executives · 20 Jul 2026
25,000 shares @ US$11.90 3.7% of flow Ordinary Shares SEC:0001193125-26-312387:0
◇ Chief Accounting Officer · Executives · 20 Jul 2026
80,000 shares @ US$11.17 11.0% of flow Ordinary Shares SEC:0001193125-26-312387:1
◇ Chief Accounting Officer · Executives · 22 Jun 2026
25,000 shares Ordinary Shares SEC:0001193125-26-281062:0
◇ Chief Accounting Officer · Executives · 22 Jun 2026
15,000 shares Ordinary Shares SEC:0001193125-26-281062:1
▼ Chief Accounting Officer · Executives · 22 Jun 2026
39,700 shares Ordinary Shares SEC:0001193125-26-281062:2
▼ Chief Accounting Officer · Executives · 22 Jun 2026
300 shares Ordinary Shares SEC:0001193125-26-281062:3
▼ Director · Executives · 11 Mar 2026
44,173 shares @ US$30.41 59.0% of flow Ordinary Shares SEC:0001193125-26-104239:0
▼ Director · Executives · 6 Mar 2026
28,186 shares @ US$29.41 36.4% of flow Ordinary Shares SEC:0001193125-26-100798:0
◇ Chief Scientific Officer · Executives · 5 Mar 2026
104,467 shares Ordinary Shares SEC:0001193125-26-099073:0
◇ Chief Executive Officer · Executives · 2 Mar 2026
443,707 shares Ordinary Shares SEC:0001193125-26-085947:0
◇ Chief Executive Officer · Executives · 24 Feb 2026
64,708 shares Ordinary Shares SEC:0001193125-26-078718:0
▼ Chief Scientific Officer · Executives · 20 Feb 2026
14,692 shares @ US$35.00 26.4% of flow Ordinary Shares SEC:0001193125-26-067260:0
◇ Chief Accounting Officer · Executives · 27 Jan 2026
39,816 shares @ US$10.90 11.1% of flow Ordinary Shares SEC:0001193125-26-029526:0
◇ Chief Accounting Officer · Executives · 23 Jan 2026
38,172 shares @ US$10.90 10.8% of flow Ordinary Shares SEC:0001193125-26-025012:0
◇ Chief Financial Officer · Executives · 20 Jan 2026
60,216 shares @ US$9.26 46.1% of flow Ordinary Shares SEC:0001193125-26-019686:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009268:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009274:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009273:0
▼ Chief Executive Officer · Executives · 7 Jan 2026
11,582 shares Ordinary Shares SEC:0001193125-26-009272:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009271:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009270:0
◆ Director · Executives · 7 Jan 2026
3,400 shares Ordinary Shares SEC:0001193125-26-009269:0
25 of 90 declarations
Load more (65 remaining) Acerca de NewAmsterdam Pharma Co N.V. NewAmsterdam Pharma Co N.V. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades metabólicas. Cotiza en NASDAQ bajo el ticker NAMS.